Tiếng Việt
ATS gets $20M order for COVID-19 vaccine syringe manufacturing line. Line to feature automation giant’s Symphoni digital manufacturing technology.
ATS Automation Tooling Systems
ATS Automation Tooling Systems Inc. announced it has received a $20 million order booking from a medical device manufacturer to design, build, and deliver several automated safety syringe manufacturing systems. It will feature the Company’s high-performance Symphoni technology. The program will be completed over the next 10 months. And then they will enable the production of safety syringes to meet potential demand related to COVID-19 vaccine production.
According to ATS, its patented Symphoni is a high-performance digital manufacturing technology characterized by its high degree of standardization, modular building blocks and a plug-and-play nature. Because a Symphoni system is digital and 100% programmable, all movements are precisely mapped out and synchronized through a technique known as electronic gearing. As such, it perfectly meets the manufacturing demands of high-volume consumables such as syringes, the company says. Since it assembles them at very high rates in a compact footprint while assuring compliance to the medical device industry’s rigid quality standards.
Symphoni
ATS’ patented Symphoni technology will figure prominently in these syringe manufacturing systems. Symphoni is an innovative, high-performance digital manufacturing technology. It multiplies the productivity of automated assembly processes by eliminating non-value-added production time. The high degree of standardization, modular building blocks and plug-and-play nature means Symphoni systems are versatile, multi-purpose production assets. Its flexibility to adapt to new products and new processes throughout their useful life. Because a Symphoni system is digital and 100% programmable, all movements are precisely mapped out and synchronized through a technique known as electronic gearing resulting in a “symphony of motion”. Symphoni’s disruptive combination of high-speed, high-precision, and configurable flexibility heralds a revolution in automated assembly. It perfectly meets the manufacturing demands of high-volume consumables such as syringes. Due to the fact that it assembles them at very high rates in a compact footprint while assuring compliance to the medical device industry’s rigid quality standards.
“Our teams remain focused on helping manufacturers address the critical need for medical equipment brought on by the COVID-19 pandemic,” said ATS CEO, Andrew Hider. “ATS’ involvement in this critical program highlights our significant capabilities in life sciences. And our ability to quickly enable manufacturers to scale production at the highest levels of quality. This demanded in the medical device industry through advanced technologies including Symphoni, our latest innovation.”
The vaccine syringe contract is related to the US Government’s Operation Warp Speed. This seeks to increase production of safety needles and syringes to meet anticipated demand.
Source: Design Engineering